Blog | Insights on drug delivery & innovation

Moving faster, with confidence: An interview with Ulrike Bauer, Chief Business Officer at Ypsomed

How can pharma and biotech companies accelerate drug-device programs without shifting risk or bottlenecks further downstream? In this interview, Ypsomed Chief Business Officer Ulrike Bauer discusses how platform flexibility, device readiness and …

For the record: How past experience enables future success

Jakob Lange and Shawn James discuss the value of the experience hidden behind metrics such as completed projects and commercialized devices – the wealth of accumulated process knowledge that enables a company to bring hard-learned lessons forwards.

Post-conference summary: Combination Products Summit 2026

The 8th Annual Combination Products Summit, organized by PharmaEd on May 27–28, 2026, brought together stakeholders from across the combination product ecosystem — pharmaceutical companies, device manufacturers, regulatory consultancies, and …

Biobased plastics in drug delivery: From material equivalence to systemic decarbonization

Biobased plastics can cut carbon without changing performance or regulatory status. In our latest blog, Nadine Kaufmann and Michael Schori explore how material equivalence, lifecycle thinking, and scale enable real decarbonization in drug delivery …

Closing the loop: Designing the future of sustainable drug delivery devices

As pharma moves toward net zero, device sustainability is under the spotlight. In our latest blog, Thuysi Dao outlines a two-pronged approach that combines sustainable device design with take-back and recycling possibilities – showcased through the …

Divergent design philosophies in the wearable injector segment

Wearable injectors come in many shapes and concepts. Our latest blog explores this diversity, and shows how YpsoDose stands out with consistent injection and minimal residual volume in large-volume self-injection.

SmartPilot - the first and only FDA-cleared connectivity solution for autoinjectors

SmartPilot is a digital add-on that transforms the YpsoMate autoinjector into a connected device. It automatically captures injection data, transmits it into the digital ecosystem, and transforms it into insights for patients, healthcare …

Milestones in manufacturing: Mastering UnoPen and YpsoPen success

UnoPen and YpsoPen are two of Ypsomed’s platforms developed and customized on behalf of various pharma customers for patients dependent on insulin but also GLP-1, hGH, FSH and PTH. Demand for these devices has now exceeded the total of 100 million …

Welcome to the Ypsomed Blog